While purchasing medicine - It is important that you let us know what other medicine you are using.
This is for preventing unwanted drug interactions.


Want to ask us a professional question ? Call us or Connect VIA Skype





Skype Me™! 
 



 
 
 
 

ROFERON-A
Home >> Search Drug By Letter >> Search Drug By Letter: R >> ROFERON-A
Search Drug By Letter : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

ROFERON-A
 
Package(a):
PREFILLED SYRINGES: 3 M.I.U.
Dosage(a):
Initial: 3 million I.U. dly. by S.C. or I.M. inject. for 16-24 wks. See prescribing information for full details.
Prescribing Restrictions Kupah Pharmacy Only Medical Division Approval 

Package(b):
PREFILLED SYRINGES: 4.5 M.I.U.
Dosage(b):
Initial: 3 million I.U. dly. by S.C. or I.M. inject. for 16-24 wks. See prescribing information for full details.
Prescribing Restrictions:    Kupah Pharmacy Only Medical Division Approval 

Package(c):
PREFILLED SYRINGES: 6 M.I.U.
Dosage(c):
Initial: 3 million I.U. dly. by S.C. or I.M. inject. for 16-24 wks. See prescribing information for full details.
Prescribing Restrictions:   Kupah Pharmacy Only Medical Division Approval  

Package(d):
PREFILLED SYRINGES: 9 M.I.U.
Dosage(d):
Initial: 3 million I.U. dly. by S.C. or I.M. inject. for 16-24 wks. See prescribing information for full details.
Prescribing Restrictions:   Kupah Pharmacy Only Medical Division Approval 

Package(e):
VIALS: 3 M.I.U.
This package has been discontinued.
Dosage(e):
Initial: 3 million I.U. dly. by S.C. or I.M. inject. for 16-24 wks. See prescribing information for full details.
Prescribing Restrictions Kupah Pharmacy Only Medical Division Approval 

Package(f):
VIALS: 4.5, 9 M.I.U.
This package has been discontinued.
Dosage(f):
Initial: 3 million I.U. dly. by S.C. or I.M. inject. for 16-24 wks. See prescribing information for full details.
Prescribing Restrictions Kupah Pharmacy Only Medical Division Approval 

Indications:
Hairy cell leukememia, condylomata acuminta, AIDS-related kaposis sarcoma, chronic viral infection of the liver type B or C (for patients over 18 years), chronic myelogic leukemia (CML). Recurring or metastatic renal cell carcinoma (RCC), follicular non-Hodgkin? lymphoma, AJCC stage II malignant melanoma free of disease after surgery
Contra-Indications:
See prescribing information for full details.
Special Precautions:
Hypersensitivity, severe pre-existing cardiac disease, severe renal or hepatic disease, epilepsy, compromised nervous system function. Severe myelosuppression. See prescribing information for full details.
Side Effects:
See prescribing information for full details.
Drug Interactions:
Centrally acting drugs. Phenytoin, theophylline, coumarin anticoagulants. Other neurotoxic, hematoxic or cardiotoxic drugs. Drugs metabolized by the liver, other immunomodulators. See prescribing information for full details.